Misonix Inc
NASDAQ:MSON (10/28/2021, 7:55:53 PM)
After market: 26.54 0 (0%)26.54
+1.2 (+4.74%)
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. The company is headquartered in Farmingdale, New York and currently employs 281 full-time employees. The firm is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.
Misonix Inc
1938 New Hwy
Farmingdale NEW YORK 11735
P: 16319279113.0
CEO: Stavros G. Vizirgianakis
Employees: 281
Website: https://misonix.com/
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Medallia, Inc. (NYSE: MDLA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $34.00 per share in cash.If you are a Medallia shareholder, click here to learn more about your rights and options. Misonix,
Here you can normally see the latest stock twits on MSON, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: